Public Company News
BlackBerry Appoints John Giamatteo as CEO
Company to Pursue Full Separation of IoT and Cybersecurity Business Units * Industry veteran Giamatteo to lead BlackBerry as Chief Executive Officer * IoT and Cybersecurity business units to become fully standalone BlackBerry divisions * Process underway to separate centralized functions and...
Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments
SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"),...
WiMi Developed Holographic Complex Amplitude Computation and Update Technology
BEIJING, Dec. 11, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it successfully developed a new technology----"Holographic Complex Amplitude Computation and Updat...
China Literature to Acquire Tencent Animation and Comics
HONG KONG, Dec. 11, 2023 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", stock code: 0772), a leading online literature and intellectual property ("IP") incubation platform inChina, today announced that it has entered into an Asset Transfer Agreement withTencent Hol...
HanAll Biopharma's Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors
WOBURN, Mass., Dec. 11, 2023 /PRNewswire/ -- HanAll Biopharma's partner NurrOn Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of Parkinson's disease (PD) and other Nurr1-related human disorders, is pleased to...
Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC for Phase III Clinical Trial
SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its submission to the Center for Drug Evaluation (CDE) of the National Medical Products Administration for the "A Randomized, Open-label, Controlled, Mu...
First Patient Dosed in U.S. Expanded Access Program for TLX250-CDx, Telix's Breakthrough Kidney Cancer Imaging Agent
MELBOURNE, Australia and INDIANAPOLIS, Dec. 11, 2023 /PRNewswire/ -- Telix
Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the
first patient has been dosed in aUnited States (U.S.) expanded access program
(EAP, ClinicalTrials.gov ID:NCT06090331
2023 SABCS | Laekna Reports Afuresertib Phase Ib Breast Cancer Study Results
- A multi-center phase Ib/III study in China and the United States led by ProfessorBinghe Xu, MD, PhD, Academician of the Chinese Academy of Engineering - 70% of the patients enrolled in phase Ib study were previously treated with CDK4/6 inhibitors - Demonstrated a confirmed objecti...
Ponsse manufactures its 20,000th forest machine
VIEREMÄ, Finland, Dec. 11, 2023 /PRNewswire/ -- The 20,000th PONSSE forest machine has been completed at Ponsse's factory in Vieremä,Finland. After the celebration on 11 December, the PONSSE Bear harvester with PONSSE H8 harvester head will go to a Norwegian customer, Lågen Skogsdrift AS. "It's ...
Forging the Future: Weichai Power's Global Strategy for Supply Chain Excellence
Strategic Partner Conference Focuses on Innovation and Collaboration in the Evolving Global Supply Chain Landscape HAIKOU, China, Dec. 11, 2023 /PRNewswire/ -- From December 10 to 11, 2023, Weichai Power (HK2338; SZ000338) hosted the Global Supply Chain Strategic Partner Cooperation Conference i...
Qudian Inc. Reports Third Quarter 2023 Unaudited Financial Results
XIAMEN, China, Dec. 11, 2023 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company, today announced its unaudited financial results for the quarter endedSeptember 30, 2023. Third Quarter 2023 Financial Highlights: * Total revenues w...
Vinamilk Earns Multiple Accolades in 2023 Brand Rankings, Underlining Its Commitment to Sustainability
HO CHI MINH CITY, Vietnam, Dec. 11, 2023 /PRNewswire/ -- Vinamilk
CHiQ Debuts at FIS Ski Jumping World Cup 2023
BERLIN, Dec. 11, 2023 /PRNewswire/ -- On December 9, Klingenthal, Germany, hosted the Men's FIS Ski Jumping World Cup, attracting top international skiers who demonstrated their courage and innovation. In a significant first, CHiQ, Changhong's premium brand known for its smart home appliances, pa...
CREAL announces the launch of its Singapore office to accelerate its Japanese real estate offering to investors in Singapore.
SINGAPORE, Dec. 11, 2023 /PRNewswire/ -- CREAL Inc, a leading Japanese real estate investment firm, listed on the Tokyo Stock Exchange (TSE), today announced the launch of itsSingapore subsidiary. CREAL, a leading Japanese real estate investment firm has two key offerings. It's real estate ...
Live from ASH 2023 | Ascentage Pharma Presents Updated Data from US Study of Olverembatinib, Further Validating Encouraging Efficacy in Patients Resistant to Ponatinib or Asciminib
SUZHOU, China, and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data from a US study ...
Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3%
SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the latest efficacy and safety...
Live from ASH 2023 | Ascentage Pharma Releases the First Dataset of Bcl-2 Inhibitor Lisaftoclax in Patients with R/R MM, Demonstrating Encouraging ORR and VGPR
SUZHOU, China and ROCKVILLE, Md., Dec. 10, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the clinical data of lisaftocl...
ChuanQi IP Launches Teaser Site for
* Blockchain-Based AFK RPG, the Third Title in the 'MIR2M' Series * Party up to 5 Characters for Simultaneous Growth, Hidden Jobs Unveiled upon Reaching Certain Levels * Various Details, Including Pre-Registration Event, to be Revealed Soon SEOUL, South Korea, Dec. 11, 2023 /PRNewswire/ -- C...
China Shenhua Included in the List of 2023 Corporate Governance Best Practice Cases
BEIJING, Dec. 11, 2023 /PRNewswire/ -- China Shenhua was recently selected as one of the 2023 Corporate Governance Best Practice Cases by the China Association for Public Companies and included in theChina Listed Company Governance Report. China Shenhua attaches great importance to corporate gov...
GCL SI Makes Waves at COP28, Showcasing Strong Commitment to Triple Renewable Energy Capacity
DUBAI, UAE, Dec. 11, 2023 /PRNewswire/ -- The critical 28th United Nations Climate Change Conference, or Conference of Parties(COP28) is currently taking place inDubai, bringing together global leaders and companies to take decisive action against climate change. As a leading renewable energy com...
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1187 media titles]
2026-11-13 22:11The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1173 media titles]
2026-11-14 13:23Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1172 media titles]
2026-11-12 23:00Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1155 media titles]
2026-11-11 22:00Kraft Heinz Casts Spotlight on its NYSE Listing: NYSE Content Update
[Picked up by 1088 media titles]
2026-11-12 21:55